| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 7 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | DURVALUMAB | 3 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 4 | ADALIMUMAB | 2 |
| 5 | FINASTERIDE | 2 |
| 6 | IBRUTINIB | 2 |
| 7 | LENALIDOMIDE | 2 |
| 8 | VENETOCLAX | 2 |
| 9 | VITAMIN C | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| 1 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 2 | PRASTERONE | 1 | 0.0004 |
| 3 | ABROCITINIB | 1 | 0.0003 |
| 4 | IVERMECTIN | 1 | 0.0002 |
| 5 | DURVALUMAB | 3 | 0.0001 |
| 6 | ADO-TRASTUZUMAB EMTANSINE | 1 | 0.0001 |
| 7 | LUBIPROSTONE | 1 | 0.0001 |
| 8 | MISOPROSTOL | 1 | 0.0001 |
| 9 | CLADRIBINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 8 |
| 1 | Kinase Inhibitor [EPC] | 3 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 3 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 2 |
| 4 | BCL-2 Inhibitor [EPC] | 2 |
| 5 | Benzodiazepine [EPC] | 2 |
| 6 | Expectorant [EPC] | 2 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 8 | Osmotic Laxative [EPC] | 2 |
| 9 | Thalidomide Analog [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 1 | 0.0002 |
| 1 | Pediculicide [EPC] | 1 | 0.0002 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 3 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 4 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 5 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 6 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 7 | Janus Kinase Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |